0001681648-20-000001.txt : 20200724
0001681648-20-000001.hdr.sgml : 20200724
20200724102147
ACCESSION NUMBER: 0001681648-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200724
DATE AS OF CHANGE: 20200724
EFFECTIVENESS DATE: 20200724
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Providence Therapeutics Inc.
CENTRAL INDEX KEY: 0001681648
IRS NUMBER: 000000000
STATE OF INCORPORATION: A0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-371760
FILM NUMBER: 201045539
BUSINESS ADDRESS:
STREET 1: 140 SUNHAVEN CLOSE SE
CITY: CALGARY
STATE: A0
ZIP: T2X 2V9
BUSINESS PHONE: 403-909-4532
MAIL ADDRESS:
STREET 1: 140 SUNHAVEN CLOSE SE
CITY: CALGARY
STATE: A0
ZIP: T2X 2V9
D
1
primary_doc.xml
X0708
D
LIVE
0001681648
Providence Therapeutics Inc.
140 SUNHAVEN CLOSE SE
CALGARY
A0
ALBERTA, CANADA
T2X 2V9
403-909-4532
ALBERTA, CANADA
None
None
Corporation
true
2015
Bradley
Sorenson
140 Sunhaven Close SE
Calgary
A0
ALBERTA, CANADA
T2X 2V9
Executive Officer
Director
Scott
Leary
14232 Caminito Vistana
San Diego
CA
CALIFORNIA
92130
Executive Officer
Director
Eric
Marcusson
239 Brannan Street
#8J
San Francisco
CA
CALIFORNIA
94107
Executive Officer
Darlene
Haslam
28 Oki Drive NW
Calgary
A0
ALBERTA, CANADA
T3B6A8
Executive Officer
Natalia
Orozco
MaRS Centre, West Tower, 661 University
Suite 1300
Toronto
A6
ONTARIO, CANADA
M5G0B7
Executive Officer
Kenneth
Hughes
229 Emerald Bay Drive
Calgary
A0
ALBERTA, CANADA
T3Z3G1
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2016-04-06
true
true
true
false
0
2223604
2223604
0
false
6
0
0
0
false
Providence Therapeutics Inc.
Bradley Sorenson
Bradley Sorenson
Chief Executive Officer
2020-07-23